Minerva Neurosciences Inc
NERV
Get informed when a big investor buys or sells
+ FollowMarket Cap$34.34M
Close$
$2.05
56.2% downside
Current Fair Value
56.2% downsideOvervalued by 56.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $34.34 Million |
|---|---|
| Enterprise Value | $66.54 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-34.67 |
| Beta | -0.1 |
| Outstanding Shares | 43,900,000 |
Return
| Return on Equity | 1129719.97% |
|---|---|
| Return on Assets | -3051932.48% |
| Return on Invested Capital | -3195073.96% |
Valuation & Multiples
| P/E Ratio | -0.52 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.78 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.98 |
| Debt to Equity | -0.26 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 12, 2026
EPS Estimate
$-0.13
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-0.19
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 452.48%▲ 147.65% |
|---|---|
| Total Invested | $230.78M▲ 114.23% |
| Investors Holding | 44▲ 14.00% |
ESG Score
No data
About Minerva Neurosciences Inc
CEO: Remy Luthringer